Recombinant human follicle-stimulating hormone and its preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- JINGZE PHARMA (HEFEI) CO LTD
- Publication Date
- 2021-10-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of proteins, and in particular relates to a polypeptide with follicle hormone activity and a preparation method for the polypeptide. Background technique
[0002] Low FSH concentration due to insufficient FSH synthesis and secretion is the main cause of female and male infertility. In women, this condition is characterized by anovulation or abnormal ovulation; in men, infertility may result from insufficient production of viable spermatozoa. In the diagnosis and treatment of infertility, FSH is a bioactive molecule that plays an important role. FSH plays an important role in human assisted reproductive technology. It is the main drug used to treat male and female infertility in the market. One of the drugs.
[0003] FSH is a heterodimeric glycoprotein with a molecular weight of about 31KD, composed of non-covalently bonded α subunits and β subunits, of which the relative molecular weight of the α subunit i...